Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Periodontal disease and late-onset aortic prosthetic vascular graft infection.

Case reports in vascular medicine

Thomas S, Ghosh J, Porter J, Cockcroft A, Rautemaa-Richardson R.
PMID: 25685592
Case Rep Vasc Med. 2015;2015:768935. doi: 10.1155/2015/768935. Epub 2015 Jan 21.

Prosthetic vascular graft infection (PVGI) is a rare but significant complication of arterial reconstructive surgery. Although the relative risk is low, the clinical consequences can be catastrophic. Microbiological data on causative bacteria are limited. We present four cases of...

Cite
Thomas S, Ghosh J, Porter J, et al. Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case Rep Vasc Med. 2015;2015:768935doi: 10.1155/2015/768935.
Thomas, S., Ghosh, J., Porter, J., Cockcroft, A., & Rautemaa-Richardson, R. (2015). Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case reports in vascular medicine, 2015768935. https://doi.org/10.1155/2015/768935
Thomas, Stephanie, et al. "Periodontal disease and late-onset aortic prosthetic vascular graft infection." Case reports in vascular medicine vol. 2015 (2015): 768935. doi: https://doi.org/10.1155/2015/768935
Thomas S, Ghosh J, Porter J, Cockcroft A, Rautemaa-Richardson R. Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case Rep Vasc Med. 2015;2015:768935. doi: 10.1155/2015/768935. Epub 2015 Jan 21. PMID: 25685592; PMCID: PMC4320805.
Copy Download .nbib Format: NLM
Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.

Therapeutic advances in medical oncology

Simões BM, Kohler B, Clarke RB, Stringer J, Novak-Frazer L, Young K, Rautemaa-Richardson R, Zucchini G, Armstrong A, Howell SJ.
PMID: 29636827
Ther Adv Med Oncol. 2018 Apr 02;10:1758835918766189. doi: 10.1177/1758835918766189. eCollection 2018.

BACKGROUND: Urogenital atrophy (UA) is a common treatment-limiting side effect of endocrine therapies. Topical estrogen is effective but systemic absorption may counter aromatase inhibitor efficacy. Numerous complementary approaches are marketed for use in UA without rigorous testing of their...

Cite
Simões BM, Kohler B, Clarke RB, et al. Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors. Ther Adv Med Oncol. 2018;10:1758835918766189doi: 10.1177/1758835918766189.
Simões, B. M., Kohler, B., Clarke, R. B., Stringer, J., Novak-Frazer, L., Young, K., Rautemaa-Richardson, R., Zucchini, G., Armstrong, A., & Howell, S. J. (2018). Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors. Therapeutic advances in medical oncology, 101758835918766189. https://doi.org/10.1177/1758835918766189
Simões, Bruno M, et al. "Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors." Therapeutic advances in medical oncology vol. 10 (2018): 1758835918766189. doi: https://doi.org/10.1177/1758835918766189
Simões BM, Kohler B, Clarke RB, Stringer J, Novak-Frazer L, Young K, Rautemaa-Richardson R, Zucchini G, Armstrong A, Howell SJ. Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors. Ther Adv Med Oncol. 2018 Apr 02;10:1758835918766189. doi: 10.1177/1758835918766189. eCollection 2018. PMID: 29636827; PMCID: PMC5888815.
Copy Download .nbib Format: NLM
Candidaemia incidence in prolonged veno-venous extracorporeal membrane oxygenation.

The Journal of hospital infection

Monk EJM, Rautemaa-Richardson R, Felton T, Montalti A, Parkes M, Templeton R, Ashworth A, Garcia M, Barker J, Thomas S.
PMID: 34562545
J Hosp Infect. 2021 Sep 22; doi: 10.1016/j.jhin.2021.09.014. Epub 2021 Sep 22.

This single-centre retrospective study reports the dynamics of candida bloodstream infection (CBSI) incidence in 145 patients receiving venovenous ECMO for respiratory support, between January 2014 and December 2018. Incidence rate and odds ratio (OR) of CBSI were calculated, stratified...

Cite
Monk EJM, Rautemaa-Richardson R, Felton T, et al. Candidaemia incidence in prolonged veno-venous extracorporeal membrane oxygenation. J Hosp Infect. 2021;doi: 10.1016/j.jhin.2021.09.014.
Monk, E. J. M., Rautemaa-Richardson, R., Felton, T., Montalti, A., Parkes, M., Templeton, R., Ashworth, A., Garcia, M., Barker, J., & Thomas, S. (2021). Candidaemia incidence in prolonged veno-venous extracorporeal membrane oxygenation. The Journal of hospital infection, . https://doi.org/10.1016/j.jhin.2021.09.014
Monk, Edward J M, et al. "Candidaemia incidence in prolonged veno-venous extracorporeal membrane oxygenation." The Journal of hospital infection vol. (2021). doi: https://doi.org/10.1016/j.jhin.2021.09.014
Monk EJM, Rautemaa-Richardson R, Felton T, Montalti A, Parkes M, Templeton R, Ashworth A, Garcia M, Barker J, Thomas S. Candidaemia incidence in prolonged veno-venous extracorporeal membrane oxygenation. J Hosp Infect. 2021 Sep 22; doi: 10.1016/j.jhin.2021.09.014. Epub 2021 Sep 22. PMID: 34562545.
Copy Download .nbib Format: NLM
Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease.

Microbiology insights

Sakko M, Rautemaa-Richardson R, Sakko S, Richardson M, Sorsa T.
PMID: 34707364
Microbiol Insights. 2021 Oct 21;14:11786361211050086. doi: 10.1177/11786361211050086. eCollection 2021.

Topical antiseptics are used to assist and further increase the effect of mechanical biofilm eradication and to potentially prevent new biofilm formation in periodontal treatment. This is of importance in treatment-resistant infections with 10% prevalence of all periodontitis cases...

Cite
Sakko M, Rautemaa-Richardson R, Sakko S, et al. Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease. Microbiol Insights. 2021;14:11786361211050086doi: 10.1177/11786361211050086.
Sakko, M., Rautemaa-Richardson, R., Sakko, S., Richardson, M., & Sorsa, T. (2021). Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease. Microbiology insights, 1411786361211050086. https://doi.org/10.1177/11786361211050086
Sakko, Marjut, et al. "Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease." Microbiology insights vol. 14 (2021): 11786361211050086. doi: https://doi.org/10.1177/11786361211050086
Sakko M, Rautemaa-Richardson R, Sakko S, Richardson M, Sorsa T. Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease. Microbiol Insights. 2021 Oct 21;14:11786361211050086. doi: 10.1177/11786361211050086. eCollection 2021. PMID: 34707364; PMCID: PMC8543563.
Copy Download .nbib Format: NLM
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM.

The Lancet. Infectious diseases

Chen SC, Perfect J, Colombo AL, Cornely OA, Groll AH, Seidel D, Albus K, de Almedia JN, Garcia-Effron G, Gilroy N, Lass-Flörl C, Ostrosky-Zeichner L, Pagano L, Papp T, Rautemaa-Richardson R, Salmanton-García J, Spec A, Steinmann J, Arikan-Akdagli S, Arenz DE, Sprute R, Duran-Graeff L, Freiberger T, Girmenia C, Harris M, Kanj SS, Roudbary M, Lortholary O, Meletiadis J, Segal E, Tuon FF, Wiederhold N, Bicanic T, Chander J, Chen YC, Hsueh PR, Ip M, Munoz P, Spriet I, Temfack E, Thompson L, Tortorano AM, Velegraki A, Govender NP.
PMID: 34419208
Lancet Infect Dis. 2021 Dec;21(12):e375-e386. doi: 10.1016/S1473-3099(21)00203-6. Epub 2021 Aug 19.

Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients who are immunocompromised or seriously ill. The major pathogens include those of the genera Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon (ie, basidiomycetes) and Kodamaea, Malassezia, Pseudozyma...

Cite
Chen SC, Perfect J, Colombo AL, et al. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2021;21(12):e375-e386doi: 10.1016/S1473-3099(21)00203-6.
Chen, S. C., Perfect, J., Colombo, A. L., Cornely, O. A., Groll, A. H., Seidel, D., Albus, K., de Almedia, J. N., Garcia-Effron, G., Gilroy, N., Lass-Flörl, C., Ostrosky-Zeichner, L., Pagano, L., Papp, T., Rautemaa-Richardson, R., Salmanton-García, J., Spec, A., Steinmann, J., Arikan-Akdagli, S., Arenz, D. E., Sprute, R., Duran-Graeff, L., Freiberger, T., Girmenia, C., Harris, M., Kanj, S. S., Roudbary, M., Lortholary, O., Meletiadis, J., Segal, E., Tuon, F. F., Wiederhold, N., Bicanic, T., Chander, J., Chen, Y. C., Hsueh, P. R., Ip, M., Munoz, P., Spriet, I., Temfack, E., Thompson, L., Tortorano, A. M., Velegraki, A., & Govender, N. P. (2021). Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. The Lancet. Infectious diseases, 21(12), e375-e386. https://doi.org/10.1016/S1473-3099(21)00203-6
Chen, Sharon C-A, et al. "Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM." The Lancet. Infectious diseases vol. 21,12 (2021): e375-e386. doi: https://doi.org/10.1016/S1473-3099(21)00203-6
Chen SC, Perfect J, Colombo AL, Cornely OA, Groll AH, Seidel D, Albus K, de Almedia JN, Garcia-Effron G, Gilroy N, Lass-Flörl C, Ostrosky-Zeichner L, Pagano L, Papp T, Rautemaa-Richardson R, Salmanton-García J, Spec A, Steinmann J, Arikan-Akdagli S, Arenz DE, Sprute R, Duran-Graeff L, Freiberger T, Girmenia C, Harris M, Kanj SS, Roudbary M, Lortholary O, Meletiadis J, Segal E, Tuon FF, Wiederhold N, Bicanic T, Chander J, Chen YC, Hsueh PR, Ip M, Munoz P, Spriet I, Temfack E, Thompson L, Tortorano AM, Velegraki A, Govender NP. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2021 Dec;21(12):e375-e386. doi: 10.1016/S1473-3099(21)00203-6. Epub 2021 Aug 19. PMID: 34419208.
Copy Download .nbib Format: NLM
Detecting Azole-Antifungal Resistance in .

Journal of fungi (Basel, Switzerland)

van der Torre MH, Novak-Frazer L, Rautemaa-Richardson R.
PMID: 31936898
J Fungi (Basel). 2020 Jan 10;6(1). doi: 10.3390/jof6010012.

Guidelines on the diagnosis and management of

Cite
van der Torre MH, Novak-Frazer L, Rautemaa-Richardson R. Detecting Azole-Antifungal Resistance in . J Fungi (Basel). 2020;6(1)doi: 10.3390/jof6010012.
van der Torre, M. H., Novak-Frazer, L., & Rautemaa-Richardson, R. (2020). Detecting Azole-Antifungal Resistance in . Journal of fungi (Basel, Switzerland), 6(1), . https://doi.org/10.3390/jof6010012
van der Torre, Mireille H, et al. "Detecting Azole-Antifungal Resistance in ." Journal of fungi (Basel, Switzerland) vol. 6,1 (2020). doi: https://doi.org/10.3390/jof6010012
van der Torre MH, Novak-Frazer L, Rautemaa-Richardson R. Detecting Azole-Antifungal Resistance in . J Fungi (Basel). 2020 Jan 10;6(1). doi: 10.3390/jof6010012. PMID: 31936898; PMCID: PMC7151159.
Copy Download .nbib Format: NLM
Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation.

The Journal of hospital infection

Monk EJM, Rautemaa-Richardson R, Felton T, Montalti A, Parkes M, Templeton R, Ashworth A, Garcia M, Barker J, Thomas S.
PMID: 34562545
J Hosp Infect. 2021 Sep 22;119:49-53. doi: 10.1016/j.jhin.2021.09.014. Epub 2021 Sep 22.

This single-centre retrospective study reports the dynamics of the incidence of candida bloodstream infection (CBSI) in 145 patients receiving venovenous extracorporeal membrane oxygenation (ECMO) for respiratory support between January 2014 and December 2018. The incidence rate and odds ratio...

Cite
Monk EJM, Rautemaa-Richardson R, Felton T, et al. Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation. J Hosp Infect. 2021;119:49-53doi: 10.1016/j.jhin.2021.09.014.
Monk, E. J. M., Rautemaa-Richardson, R., Felton, T., Montalti, A., Parkes, M., Templeton, R., Ashworth, A., Garcia, M., Barker, J., & Thomas, S. (2021). Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation. The Journal of hospital infection, 11949-53. https://doi.org/10.1016/j.jhin.2021.09.014
Monk, E J M, et al. "Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation." The Journal of hospital infection vol. 119 (2021): 49-53. doi: https://doi.org/10.1016/j.jhin.2021.09.014
Monk EJM, Rautemaa-Richardson R, Felton T, Montalti A, Parkes M, Templeton R, Ashworth A, Garcia M, Barker J, Thomas S. Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation. J Hosp Infect. 2021 Sep 22;119:49-53. doi: 10.1016/j.jhin.2021.09.014. Epub 2021 Sep 22. PMID: 34562545.
Copy Download .nbib Format: NLM
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Rautemaa-Richardson R, Koehler P, Lagrou K, Hoenigl M.
PMID: 34454093
Clin Microbiol Infect. 2021 Aug 26; doi: 10.1016/j.cmi.2021.08.014. Epub 2021 Aug 26.

OBJECTIVES: Coronavirus disease 2019 (COVID-19) -associated pulmonary aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The objectives of this multinational study were to determine the prevalence of CAPA in patients with COVID-19 in intensive care...

Cite
Prattes J, Wauters J, Giacobbe DR, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021;doi: 10.1016/j.cmi.2021.08.014.
Prattes, J., Wauters, J., Giacobbe, D. R., Salmanton-García, J., Maertens, J., Bourgeois, M., Reynders, M., Rutsaert, L., Van Regenmortel, N., Lormans, P., Feys, S., Reisinger, A. C., Cornely, O. A., Lahmer, T., Valerio, M., Delhaes, L., Jabeen, K., Steinmann, J., Chamula, M., Bassetti, M., Hatzl, S., Rautemaa-Richardson, R., Koehler, P., Lagrou, K., Hoenigl, M. (2021). Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, . https://doi.org/10.1016/j.cmi.2021.08.014
Prattes, Juergen, et al. "Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. (2021). doi: https://doi.org/10.1016/j.cmi.2021.08.014
Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Rautemaa-Richardson R, Koehler P, Lagrou K, Hoenigl M. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021 Aug 26; doi: 10.1016/j.cmi.2021.08.014. Epub 2021 Aug 26. PMID: 34454093; PMCID: PMC8387556.
Copy Download .nbib Format: NLM
Absence of Azole Antifungal Resistance in .

Journal of fungi (Basel, Switzerland)

van der Torre MH, Whitby C, Eades CP, Moore CB, Novak-Frazer L, Richardson MD, Rautemaa-Richardson R.
PMID: 33036151
J Fungi (Basel). 2020 Oct 06;6(4). doi: 10.3390/jof6040208.

The emergence of azole-resistant

Cite
van der Torre MH, Whitby C, Eades CP, et al. Absence of Azole Antifungal Resistance in . J Fungi (Basel). 2020;6(4)doi: 10.3390/jof6040208.
van der Torre, M. H., Whitby, C., Eades, C. P., Moore, C. B., Novak-Frazer, L., Richardson, M. D., & Rautemaa-Richardson, R. (2020). Absence of Azole Antifungal Resistance in . Journal of fungi (Basel, Switzerland), 6(4), . https://doi.org/10.3390/jof6040208
van der Torre, Mireille H, et al. "Absence of Azole Antifungal Resistance in ." Journal of fungi (Basel, Switzerland) vol. 6,4 (2020). doi: https://doi.org/10.3390/jof6040208
van der Torre MH, Whitby C, Eades CP, Moore CB, Novak-Frazer L, Richardson MD, Rautemaa-Richardson R. Absence of Azole Antifungal Resistance in . J Fungi (Basel). 2020 Oct 06;6(4). doi: 10.3390/jof6040208. PMID: 33036151; PMCID: PMC7711775.
Copy Download .nbib Format: NLM
Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students.

JAC-antimicrobial resistance

McMaster D, Courtenay M, Santucci C, Davies AP, Kirby A, Seddon O, Price DA, Barlow G, Lim FH, Davies BS, O'Shea MK, Collini P, Basarab M, Ahmad A, Albur M, Hemsley C, Brown NM, O'Gorman C, Rautemaa-Richardson R, Davies GR, Penfold CN, Patel S.
PMID: 34223048
JAC Antimicrob Resist. 2020 Dec 04;2(4):dlaa096. doi: 10.1093/jacamr/dlaa096. eCollection 2020 Dec.

BACKGROUND: In the UK there is limited coverage of antimicrobial stewardship across postgraduate curricula and evidence that final year medical students have insufficient and inconsistent antimicrobial stewardship teaching. A national undergraduate curriculum for antimicrobial resistance and stewardship is required...

Cite
McMaster D, Courtenay M, Santucci C, et al. Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students. JAC Antimicrob Resist. 2020;2(4):dlaa096doi: 10.1093/jacamr/dlaa096.
McMaster, D., Courtenay, M., Santucci, C., Davies, A. P., Kirby, A., Seddon, O., Price, D. A., Barlow, G., Lim, F. H., Davies, B. S., O'Shea, M. K., Collini, P., Basarab, M., Ahmad, A., Albur, M., Hemsley, C., Brown, N. M., O'Gorman, C., Rautemaa-Richardson, R., Davies, G. R., Penfold, C. N., Patel, S. (2020). Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students. JAC-antimicrobial resistance, 2(4), dlaa096. https://doi.org/10.1093/jacamr/dlaa096
McMaster, David, et al. "Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students." JAC-antimicrobial resistance vol. 2,4 (2020): dlaa096. doi: https://doi.org/10.1093/jacamr/dlaa096
McMaster D, Courtenay M, Santucci C, Davies AP, Kirby A, Seddon O, Price DA, Barlow G, Lim FH, Davies BS, O'Shea MK, Collini P, Basarab M, Ahmad A, Albur M, Hemsley C, Brown NM, O'Gorman C, Rautemaa-Richardson R, Davies GR, Penfold CN, Patel S. Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students. JAC Antimicrob Resist. 2020 Dec 04;2(4):dlaa096. doi: 10.1093/jacamr/dlaa096. eCollection 2020 Dec. PMID: 34223048; PMCID: PMC8210211.
Copy Download .nbib Format: NLM
Molecular Epidemiology of .

Journal of fungi (Basel, Switzerland)

van der Torre MH, Shen H, Rautemaa-Richardson R, Richardson MD, Novak-Frazer L.
PMID: 33672698
J Fungi (Basel). 2021 Feb 20;7(2). doi: 10.3390/jof7020152.

Molecular fungal genotyping techniques developed and employed for epidemiological studies have understandably concentrated on establishing the genetic diversity of

Cite
van der Torre MH, Shen H, Rautemaa-Richardson R, et al. Molecular Epidemiology of . J Fungi (Basel). 2021;7(2)doi: 10.3390/jof7020152.
van der Torre, M. H., Shen, H., Rautemaa-Richardson, R., Richardson, M. D., & Novak-Frazer, L. (2021). Molecular Epidemiology of . Journal of fungi (Basel, Switzerland), 7(2), . https://doi.org/10.3390/jof7020152
van der Torre, Mireille H, et al. "Molecular Epidemiology of ." Journal of fungi (Basel, Switzerland) vol. 7,2 (2021). doi: https://doi.org/10.3390/jof7020152
van der Torre MH, Shen H, Rautemaa-Richardson R, Richardson MD, Novak-Frazer L. Molecular Epidemiology of . J Fungi (Basel). 2021 Feb 20;7(2). doi: 10.3390/jof7020152. PMID: 33672698; PMCID: PMC7924367.
Copy Download .nbib Format: NLM
Impact of airway Exophiala spp. on children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Mills R, Rautemaa-Richardson R, Wilkinson S, Patel L, Maitra A, Horsley A.
PMID: 33775601
J Cyst Fibros. 2021 Jul;20(4):702-707. doi: 10.1016/j.jcf.2021.03.012. Epub 2021 Mar 26.

INTRODUCTION: Isolation of Exophiala species from sputum samples has become increasingly reported in Cystic Fibrosis (CF). However, the clinical significance of Exophiala spp. with regards to the paediatric CF population is unknown.METHODS: A case control study was undertaken to...

Cite
Mills R, Rautemaa-Richardson R, Wilkinson S, et al. Impact of airway Exophiala spp. on children with cystic fibrosis. J Cyst Fibros. 2021;20(4):702-707doi: 10.1016/j.jcf.2021.03.012.
Mills, R., Rautemaa-Richardson, R., Wilkinson, S., Patel, L., Maitra, A., & Horsley, A. (2021). Impact of airway Exophiala spp. on children with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 20(4), 702-707. https://doi.org/10.1016/j.jcf.2021.03.012
Mills, Rowena, et al. "Impact of airway Exophiala spp. on children with cystic fibrosis." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 20,4 (2021): 702-707. doi: https://doi.org/10.1016/j.jcf.2021.03.012
Mills R, Rautemaa-Richardson R, Wilkinson S, Patel L, Maitra A, Horsley A. Impact of airway Exophiala spp. on children with cystic fibrosis. J Cyst Fibros. 2021 Jul;20(4):702-707. doi: 10.1016/j.jcf.2021.03.012. Epub 2021 Mar 26. PMID: 33775601.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries